Related Experiment Video
Updated: Jun 16, 2026

An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion Injury
Published on: July 15, 2021
Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury
Krisztina Rusai1, Daniel Sollinger, Marcus Baumann
1Department of Nephrology, Technical University Munich, Klinikum rechts der Isar, Ismaninger Str. 22, Munich, Germany.
Abstract:
Toll-like receptors (TLRs) are an evolutionarily conserved family of cell membrane receptors that are part of the innate immunity system playing an important role as a first response to tissue injury. TLR2 and TLR4 are constitutively expressed on renal epithelium, and their expression is enhanced following renal ischemia/reperfusion (I/R) injury. Genetic deletion of either TLR2 or TLR4 protects from renal I/R injury. However, it is not known whether deletion of both combined protects the kidney more than a deletion of either one alone. Therefore, we performed renal I/R injury in mice lacking TLR2, TLR4, and TLR2/4, respectively. Our results demonstrate that there are no significant differences regarding protection from renal I/R injury in TLR2/4((-/-)) compared with either TLR2((-/-)) or TLR4((-/-)) gene-targeted mice as determined by histological evaluation and renal functional parameters. Furthermore, there was no difference in the number of apoptotic tubular cells and in nuclear translocation of nuclear factor kappa-B (NF-kappaB) between the TLR-gene-targeted groups. In parallel, in vitro experiments did not demonstrate an additional effect of the double genetic deletion compared with the single gene deletion with respect to tumor necrosis factor (TNF)-alpha and interleukin (IL)-8 production in hypoxic isolated proximal tubular epithelial cells of the respective animals. In conclusion, a double genetic deletion of TLR2 and TLR4 confers a similar protection following renal I/R injury compared with single deletions of TLR2 and TLR4.
Insights
Deleting both Toll-like receptors (TLR2 and TLR4) did not offer greater kidney protection against ischemia/reperfusion injury than deleting either receptor alone. Combined TLR2/4 deletion showed similar outcomes to single TLR2 or TLR4 gene deletion.
Area of Science:
- Immunology
- Renal Physiology
- Cell Biology
Background:
- Toll-like receptors (TLRs) are key components of innate immunity, crucial for responding to tissue injury.
- TLR2 and TLR4 are present on kidney cells and their levels increase after ischemia/reperfusion (I/R) injury.
- Individual deletion of TLR2 or TLR4 protects kidneys from I/R injury.
Purpose of the Study:
- To investigate if combined deletion of TLR2 and TLR4 provides enhanced protection against renal I/R injury compared to single deletions.
- To compare the effects of TLR2, TLR4, and combined TLR2/4 gene deletion on kidney histology, function, and cellular damage markers.
Main Methods:
- Induction of renal I/R injury in mice genetically modified to lack TLR2, TLR4, or both TLR2 and TLR4.
- Assessment of kidney injury through histological evaluation and measurement of renal function parameters.
- Analysis of tubular cell apoptosis and nuclear factor-kappaB (NF-kappaB) translocation.
- In vitro studies using isolated proximal tubular epithelial cells to measure cytokine production (TNF-alpha, IL-8) under hypoxic conditions.
Main Results:
- No significant difference in protection against renal I/R injury was observed between mice lacking both TLR2 and TLR4 (TLR2/4((-/-))) and those lacking only TLR2 (TLR2((-/-))) or only TLR4 (TLR4((-/-))).
- Histological and functional assessments showed comparable levels of kidney protection across all gene-targeted groups.
- Apoptotic cell counts and NF-kappaB activation were similar in TLR2((-/-)), TLR4((-/-))), and TLR2/4((-/-))) mice.
- In vitro experiments revealed no additional benefit of combined TLR2/4 deletion on TNF-alpha and IL-8 production compared to single deletions.
Conclusions:
- Combined genetic deletion of TLR2 and TLR4 does not confer superior protection to the kidney following I/R injury compared to the deletion of either TLR2 or TLR4 alone.
- The study suggests that targeting both TLR2 and TLR4 simultaneously may not offer additive benefits for mitigating renal I/R injury.
- These findings contribute to understanding the specific roles of TLR2 and TLR4 in renal injury and immunity.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Cellular Injury IV: Necrosis
Acute Kidney Injury I: Introduction
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
